Recombinant IL6R (Levilimab Biosimilar) antibody

Catalog No. ABIN7597783

The Humanized Chimeric anti-IL6R (Levilimab Biosimilar) antibody is suitable to detect IL6R (Levilimab Biosimilar) in samples from Human.

Quick Overview for Recombinant IL6R (Levilimab Biosimilar) antibody (ABIN7597783)

Target: IL6R (Levilimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Grade: Research Grade

Product Details anti-IL6R (Levilimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Levilimab Biosimilar Antibody

Specificity: SIL6R, Interleukin-6 receptor subunit alpha, CD126, IL-6R 1, IL-6R subunit alpha, Membrane glycoprotein 80, gp80, IL6R, IL-6RA, IL-6 receptor subunit alpha, IL-6R-alpha

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for IL6R (Levilimab Biosimilar)

Target: IL6R (Levilimab Biosimilar)

Alternative Name: Levilimab Biosimilar

Target Type: Biosimilar

Background: SIL6R, Interleukin-6 receptor subunit alpha, CD126, IL-6R 1, IL-6R subunit alpha, Membrane glycoprotein 80, gp80, IL6R, IL-6RA, IL-6 receptor subunit alpha, IL-6R-alpha

UniProt: P08887

CAS-No: 2035008-70-7